Clodoveo Ferri

| birth_place = Cropani, Calabria, Italy | field = Rheumatology | occupation = Italian research scientist | workplaces = University of Modena and Reggio Emilia | alma_mater = University of Pisa (1972) | footnotes = | signature = }} Clodoveo Ferri (born 22 March 1947) is an Italian researcher in the field of clinical rheumatology, immunology and internal medicine. A native of Cropani, a small town in Calabria, Italy, Clodoveo Ferri graduated cum laude from the University of Pisa and later specialized in internal medicine and rheumatology.

From January 2003 to November 2017, Clodoveo Ferri was Professor of Rheumatology, Chief of the Chair of Rheumatology and director of the Postgraduate School of Rheumatology at the University of Modena and Reggio Emilia in Modena, Italy. Following his retirement, he continued his activity as a research collaborator at the same University.[https://personale.unimore.it/Rubrica/dettaglio/clferri]

Since 1972, the majority of Ferri's work is mainly devoted tof systemic sclerosis, cryoglobulinemic vasculitis (mixed cryoglobulinemia) and other autoimmune systemic disorders.

His most notable discovery regard the causative role of the hepatitis C virus (HCV) in the majority of patients with mixed cryoglobulinemia (cryoglobulinemic vasculitis) and in a significant percentage of patients with B-cell non-Hodgkin's lymphoma.

Ferri is a member of the SIR (Italian Society of Rheumatology) and GISC (Italian Group for the Study of Cryoglobulinemias), and an international fellow of the American College of Rheumatology. Provided by Wikipedia